The effect of Phoneutria nigriventer (armed spider) venom on arterial blood pressure of anaesthetised rats

European Journal of Pharmacology

Volumn 298, Issue 2, 1996, Pages 113-120

  Costa, Soraia K P ^a   Moreno Jr , Heitor ^a   Brain, Susan D ^b   De Nucci, Gilberto ^a   Antunes, Edson ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Ca2+ channel blocker; Endothelin 1; Hoe 140; K+ channel blocker; Nitric oxide (NO); Spider venom

Indexed keywords

1,4 DIHYDRO 2,6 DIMETHYL 5 NITRO 4 [2 (TRIFLUOROMETHYL)PHENYL] 3 PYRIDINECARBOXYLIC ACID METHYL ESTER; 2 [[2 [[2 [[(HEXAHYDRO 1H AZEPIN 1 YL)CARBONYL]AMINO] 4 METHYLPENTANOYL]AMINO] 3 (1 METHYL 1H INDOL 3 YL)PROPIONYL]AMINO] 3 (2 PYRIDYL)PROPIONIC ACID; ACETYLCHOLINE; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; APAFANT; ATROPINE; BRADYKININ B2 RECEPTOR ANTAGONIST; CALCIUM CHANNEL BLOCKING AGENT; DILTIAZEM; ENDOTHELIN 1; ENDOTHELIN A RECEPTOR ANTAGONIST; GLIBENCLAMIDE; ICATIBANT; INDOMETACIN; LOSARTAN; N(G) NITROARGININE METHYL ESTER; NEUROKININ 1 RECEPTOR ANTAGONIST; NEUROKININ 2 RECEPTOR ANTAGONIST; NIFEDIPINE; NITRIC OXIDE SYNTHASE INHIBITOR; NOLPITANTIUM; PHENOXYBENZAMINE; POTASSIUM CHANNEL; POTASSIUM CHANNEL BLOCKING AGENT; PROPRANOLOL; SAREDUTANT; SPIDER VENOM; THROMBOCYTE ACTIVATING FACTOR; THROMBOCYTE ACTIVATING FACTOR ANTAGONIST; UNINDEXED DRUG; VERAPAMIL;

ANESTHESIA; ANIMAL EXPERIMENT; ARTICLE; BREATHING DISORDER; CALCIUM TRANSPORT; CONTROLLED STUDY; DEFECATION; DOSE TIME EFFECT RELATION; FASCICULATION; HYPERTENSION; HYPOTENSION; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PRIORITY JOURNAL; RAT; SALIVATION; TACHYCARDIA;

EID: 0029876783     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/0014-2999(95)00739-3     Document Type: Article

References (37)

1. Antunes, E., R.A. Marangoni, S.D. Brain and G. De Nucci, 1992, Phoneutria nigriventer (armed spider) venom induces increased vascular permeability in rat and rabbit skin in vivo, Toxicon 30, 1011.
2. Antunes, E., R.A. Marangoni, N.C.C. Borges, S. Hyslop, M.D. Fontana and G. De Nucci, 1993a, Effect of Phoneutria nigriventer venom on rabbit vascular smooth muscle, Braz. J. Med. Biol. Res. 26, 81.
3. Antunes, E., R.A. Marangoni, J.R. Giglio, S.D. Brain and G. De Nucci, 1993b, Activation of tissue kallikrein-kininogen-kinin system in rabbit skin by a fraction isolated from Phoneutria nigriventer (armed spider) venom, Toxicon 31, 1385.
4. Arai, S., S. Hori, I. Aramori, H. Ohkubo and S. Nakanishi, 1990, Cloning and expression of a cDNA encoding an endothelin receptor, Nature 348, 730.
5. Bdolah, A., Z. Wollberg, G. Fleminger and E. Kochva, 1989, SRTX-d, a new native peptide of the endothelin/sarafotoxin family, FEBS Lett. 256, 1.
6. Bento, A.C., E. Rego, S.R. Pedroso-Mariani, L.C. Mancuso, J.R. Giglio, J.C. Novello, S. Marangoni, I. Caracelli, B. Oliveira, E. Antunes and G. De Nucci, 1995, Isolation of a polypeptide from Phoneutria nigriventer venom responsible for the increased vascular permeability in rabbit skin, Toxicon 33, 171.
7. Bhoola, K.D., C.D. Figueroa and K. Worthy, 1992, Bioregulation of kinins: kallikreins, kininogens and kininases, Pharmacol. Rev. 44, 4.
8. Braquet, P., T.Y. Shen, L. Touqui and B.B. Vargaftig, 1987, Perspectives in platelet-activating factor research, Pharmacol. Rev. 39, 97.
9. Brazil, V. and J. Vellard, 1925, Contribuição ao estudo de venenos de aranhas I, Mem. Inst. Butantan 2, 1.
10. Casals-Stenzel, J.G., G. Muacevic and K.H. Weber, 1986, WEB 2086, a new and specific antagonist of platelet-activating factor (PAF) in vitro and in vivo, Naunyn-Schmied. Arch. Pharmacol. 334, R44.
11. Chiu, AT., D.E. McCall, W.A. Price, P.C. Wong, D.J. Carini, J.V. Duncia, R.R. Wexler, S.E. Yoo, A.L. Johnson and P.B.B.W.M. Timmermans, 1990, The non-peptide angiotensin II receptor antagonists: cellular and biochemical pharmacology of losartan, an orally active antihypertensive agent, J. Pharmacol. Exp. Ther. 252, 711.
12. Cho, C. and A.W. Pruitt, 1986, Therapeutic uses of calcium-channels blocking drugs in the young, Am. J. Dis. Child. 140, 360.
13. Cook, N.S., 1988, The pharmacology of potassium channels and their therapeutic potential, Trends Pharmacol. Sci. 9, 21.
14. De Nucci, G., R.J. Gryglewski, T.D. Warner and J.R. Vane, 1988, Receptor-mediated release of endothelium-derived relaxing factor and prostacyclin from bovine aortic endothelial cells is coupled, Proc. Natl. Acad. Sci. USA 85, 2334.
15. Edwards, G. and A.H. Weston, 1990, Potassium channel openers and vascular smooth muscle relaxation, Pharmacol. Ther. 48, 237.
16. 2) receptor, Life Sci. 50, PL101.
17. 1 receptor antagonist, Eur. J. Pharmacol. 250, 403.
18. Fontana, M.D. and O. Vital-Brazil, 1985, Mode of action of Phoneutria nigriventer spider venom at the isolated phrenic nerve-diaphragm of the rat, Braz. J. Med. Biol. Res. 18, 557.
19. Furchgott, R.F. and J.V. Zawadzki, 1980, The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine, Nature 288, 373.
20. Hamberg, M., J. Svensson and B. Samuelsson, 1975, Thromboxanes: a new family of biologically active compounds derived from prostaglandin endoperoxides, Proc. Natl. Acad. Sci. USA 172, 2994.
21. Herbette, L.G., P.E. Mason, K.R. Sweeney, M.W. Trumbore and R.P. Mason, 1994, Favorable amphiphilicity of nimodipine facilitates its interactions with brain membranes, Neuropharmacology 33, 241.
22. Lopes-Martins, R.A.B., E. Antunes, M.L.V. Oliva, C.A.M. Sampaio, J. Burton and G. De Nucci, 1994, Pharmacological characterisation of rabbit corpus cavernosum relaxation mediated by the tissue kallikrein-kinin system, Br. J. Pharmacol. 113, 81.
23. Lucas, S., 1988, Spiders in Brazil, Toxicon 26, 759.
24. Marangoni, R.A., E. Antunes, S.D. Brain and G. De Nucci, 1993a, Activation by Phoneutria nigriventer (armed spider) venom of tissue kallikrein-kininogen-kinin system in rabbit skin in vivo, Br. J. Pharmacol. 109, 539.
25. Marangoni, S., N.C.C. Borges, R.A. Marangoni, E. Antunes, A.C. Vieira, J.C. Novello, G.B. Domont, J.R. Giglio, B. Oliveira and G. De Nucci, 1993b, Biochemical characterization of a vascular smooth muscle contracting polypeptide purified from Phoneutria nigriventer (armed spider) venom, Toxicon 31, 377.
26. Moncada, S., R. Gryglewski, S. Bunting and J.R. Vane, 1976, An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation, Nature 263, 663.
27. G-Nitro arginine (L-NOARG), a novel L-arginine-reversible inhibitor of endothelium-dependent vasodilation in vitro, Br. J. Pharmacol. 99, 408.
28. 1 receptor antagonist SR140333 on the oedema formation induced in rat skin by venom from the Phoneutria nigriventer spider, Br. J. Pharmacol. 114, 353P.
29. Porter, C.J., A. Garson and P.C. Gilette, 1983, Verapamil: an effective calcium blocking agent for pediatric patients, Pediatrics 71, 748.
30. 2+ entry linked to rapid glutamate release: studies using the Phoneutria nigriventer toxin PhTX2 and potassium depolarization, Biochem. J. 296, 313.
31. Schenberg, S. and F.A. Pereira-Lima, 1971, Phoneutria nigriventer venom. Pharmacology and biochemistry of its components, in: Venomous Animals and their Venoms, Vol. 3, eds. W. Bucherl and E.E. Buckley (Academic Press, New York) p. 279.
32. A receptor antagonist, J. Pharmacol. Exp. Ther. 264, 1040.
33. Spedding, M. and R. Paoletti, 1992, Classification of calcium channels and the sites of action of drugs modifying channel function, Pharmacol, Rev. 44, 363.
34. Vital-Brazil, O., G.B. Leite and M.D. Fontana, 1988, Modo de ação da peçonha da aranha armadeira, Phoneutria nigriventer (Keyserling, 1891), nas aurículas isoladas de cobaia, Ciênc. Cult. S Paulo 40, 181.
35. Wagner, J.G., A.P. Rochini and J. Vasiliades, 1982, Prediction of steady-state verapamil plasma concentrations in children and adults, Clin. Pharmacol. Ther. 32, 172.
36. Wirth, K., F.J. Hock, U. Albus, W. Linz, H.G. Alpermann, H. Anagnostopoulos, St. Henke, G. Breipohl, W. Konig, J. Knolle and B.A. Scholkens, 1991, Hoe 140, a new potent and long-acting bradykinin antagonist: in vivo studies, Br. J. Pharmacol. 102, 774.
37. Yanagisawa, M., H. Kurihara, S. Kimura, Y. Tomobe, M. Kobayashi, Y. Mitsui, Y. Yazaki, K. Goto and T. Masaki, 1988, A novel potent vasoconstrictor peptide produced by vascular endothelial cells, Nature 332, 411.